Scientists Discover Protein That Triggers Diabetic Blindness as Drug Enters Clinical Trials
UCL researchers identify the LRG1 protein as the earliest trigger of diabetic blindness, with a drug targeting the protein now ready for clinical trials that could prevent vision loss in millions.